Arkolith/Insider Trading/APGE/Form 4

Henderson Michael Thomas

Chief Executive Officer, DirectorApogee Therapeutics, Inc. (APGE) · full profile →Form 4 · filed Dec 12, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.5M
Net Open-Market Flow
-$1.5M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 10, 2025Sell(S)9K$74.88$706K1.2M
Dec 10, 2025Sell(S)10K$75.79$758K1.2M
Dec 10, 2025Sell(S)560$76.58$43K1.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-120758) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML